Sectoral Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Sectoral Asset Management’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,800	Closed	-$242K	–	103
2024 Q1	$242K	Sell	8,800 -500	-5%	-$13.9K	0.1%	87
2023 Q4	$284K	Sell	9,300 -103,032	-92%	-$2.96M	0.12%	93
2023 Q3	$3.55M	Buy	112,332 +11,500	+11%	+$446K	0.69%	62
2023 Q2	$4.11M	Buy	100,832 +98,352	+3,966%	+$3.99M	0.69%	64
2023 Q1	$92.4K	Sell	2,480 -68,900	-97%	-$2.7M	0.02%	117
2022 Q4	$2.49M	Hold	71,380	–	–	0.48%	71
2022 Q3	$3.99M	Hold	71,380	–	–	0.79%	59
2022 Q2	$3.69M	Sell	71,380 -820	-1%	-$41.6K	0.74%	59
2022 Q1	$5.25M	Buy	72,200 +600	+0.8%	+$50.8K	0.93%	40
2021 Q4	$8.47M	Buy	71,600 +8,700	+14%	+$1.09M	1.27%	31
2021 Q3	$8.44M	Buy	+62,900	New	+$9.52M	0.7%	60
2016 Q4	–	Sell	-123,159	Closed	-$2.32M	–	59
2016 Q3	$2.32M	Hold	123,159	–	–	0.23%	51
2016 Q2	$1.47M	Buy	+123,159	New	+$3.28M	0.15%	57

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sectoral Asset Management's NTLA Position: Q2 2024 in Review

Sectoral Asset Management sold out of Intellia Therapeutics (NTLA) in Q2 2024, closing a stake of 8,800 shares — an estimated $242K sold.

Sectoral Asset Management first reported a position in NTLA in Q2 2016 and held it in 13 quarters. The position peaked at $8.47M in Q4 2021. 290 funds tracked by Wall St. Rank hold NTLA as of Q2 2024.

Sectoral Asset Management reported no remaining Intellia Therapeutics position as of Q2 2024 after selling out during the quarter.
Sectoral Asset Management sold 8,800 Intellia Therapeutics shares in Q2 2024, an estimated $242K.
Sectoral Asset Management first reported a position in Intellia Therapeutics in Q2 2016 and held it in 13 quarters.
Sectoral Asset Management's Intellia Therapeutics position peaked at $8.47M in Q4 2021.
290 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2024.

Based on Sectoral Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.